Absci (NASDAQ:ABSI – Get Free Report) issued its quarterly earnings data on Thursday. The company reported ($0.25) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.23) by ($0.02), Yahoo Finance reports. The firm had revenue of $0.34 million for the quarter, compared to analyst estimates of $1.75 million. Absci had a […]
Dimension Capital Management LLC Buys Shares of 21,584 Absci Co. (NASDAQ:ABSI) theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
Fate Therapeutics (NASDAQ:FATE – Get Free Report) announced its quarterly earnings data on Monday. The biopharmaceutical company reported ($0.45) earnings per share for the quarter, beating the consensus estimate of ($0.57) by $0.12, MarketWatch Earnings reports. Fate Therapeutics had a negative return on equity of 36.63% and a negative net margin of 253.30%. The company […]
Fate Therapeutics (NASDAQ:FATE – Get Free Report) released its earnings results on Monday. The biopharmaceutical company reported ($0.45) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.57) by $0.12, MarketWatch Earnings reports. Fate Therapeutics had a negative return on equity of 36.63% and a negative net margin of 253.30%. The firm […]
Fate Therapeutics (NASDAQ:FATE) Given New $7.00 Price Target at Wedbush themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.